CD9 anticorps
-
- Antigène Voir toutes CD9 Anticorps
- CD9
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD9 est non-conjugé
-
Application
- Flow Cytometry (FACS)
- Specificité
- Human/Hamster/Canine/Feline/Monkey/Rabbit/Raccoon CD9, Mr 24 kDa
- Attributs du produit
- Mouse Anti-Human CD9-UNLB
- Purification
- Purified
- Immunogène
- Unknown
- Clone
- MM2-57
- Isotype
- IgG2b
- Top Product
- Discover our top product CD9 Anticorps primaire
-
-
- Indications d'application
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and PE conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
- Commentaires
-
platelet inhibition and aggregation studies
- Volume d'échantillon
- 1 mL
- Restrictions
- For Research Use only
-
- Concentration
- 0.1 mg/mL
- Buffer
- 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
- Agent conservateur
- Without preservative
- Conseil sur la manipulation
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- Stock
- 4 °C
- Stockage commentaire
- Store at 2-8°C
-
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." dans: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
: "
-
Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." dans: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
-
- Antigène
- CD9
- Autre désignation
- CD9 (CD9 Produits)
- Synonymes
- anticorps BTCC-1, anticorps DRAP-27, anticorps MIC3, anticorps MRP-1, anticorps TSPAN-29, anticorps TSPAN29, anticorps Tspan29, anticorps cd9, anticorps wu:fb61g04, anticorps zgc:73383, anticorps zgc:85743, anticorps CD9 molecule, anticorps CD9 antigen, anticorps CD9 molecule a, anticorps CD9, anticorps Cd9, anticorps cd9a
- Sujet
- CD9 is a 24 kDa member of the transmembrane 4 superfamily (TM4-SF) of cell surface receptors. It is expressed strongly on platelets, lymphoid progenitor cells, activated lymphocytes and endothelia, and, weakly, on eosinophils, granulocytes, monocytes, and macrophages. CD9 functions as an adhesion molecule where it mediates platelet aggregation and activation.
- Pathways
- Response to Water Deprivation, Cell-Cell Junction Organization
-